1Choi HK,Merkel PA,Walker AM,et al.Drug- associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of anti-myeloperoxidase antibodies[].Arthritis and Rheumatism.2000
2Kitahara T,Hiromura K,Maezawa A,et al.Case of propylthiouracilinduced vasculitis associated with anti-neutrophil cytoplasmic antibody(ANCA)[].Clinical Nephrology.1997
3Harper L,Cockwell P,Savage CO.Case of propylthiouracil- induced ANCA associated small vessel vasculitis[].Nephrology Dialysis Transplantation.1998
4Short AK,Lockwood CM.Antigen specificity in hydralazine associated ANCA positive systemic vasculitis[].Quarterly Journal of Mathematics.1995
5Dolman KM,Gans RO,Vervaat TJ,et al.Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy[].The Lancet.1993
6Tanemoto M,Miyakawa H,Hanai J,et al.Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the coure of Graves′disease: report of three adult cases[].American Journal of Kidney Diseases.1995
7Yuasa S,Hashimoto M,Yura T,et al.Antineutrophil cytoplasmic antibodies ( ANCA )-associated crescentic glomerulonephritis and propylthiouracil therapy[].Nephron.1996
9Dhillon SS,Singh D,Doe N,et al.Diffuse alveolar hemorrhage and pulmonary capillaritis due to propylthiouracil[].Chest.1999
10Honda H,Shibata T,Hara H,et al.MPO-ANCA in patients with Graves′ disease, strong association with propylthiouracil therapy〔abstract〕[].Sarcoidosis Vasc Diffuse Lung Dis.1996
9Yamada A, Sato K, Hara M, et al. Propylthiouracil-induced lupus-like syndrome developing in a Graves' patient with a sibling with systemic lupus erythematosus [J]. Intern Med, 2002, 41 (12) : 1204-1208.
10Noh JY, Asari T, Hamada N, et al. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO- ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations[J]. Clin Endocrinol (Oxf), 2001, 54(5): 651-654.
